Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
05/24/2011 | CA2342064C Long wave length absorbing bacteriochlorin alkyl ether analogs |
05/24/2011 | CA2266640C Methods for treating an ischemic disorder and improving stroke outcome |
05/19/2011 | WO2011059478A1 Th1/th2 polarizing vaccines |
05/19/2011 | WO2011058002A1 Labelled pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their use in diagnostic methods |
05/19/2011 | WO2011057411A1 Ovarian markers of oocyte competency and uses thereof |
05/19/2011 | WO2010151074A3 Photosensitizer containing conjugates of quantum dot-chlorine derivatives and composition for treating and diagnosing cancer containing same for photodynamic therapy |
05/19/2011 | US20110118532 Brachytherapy seed |
05/19/2011 | US20110117105 Method of treating immune disease using b-cell antibodies |
05/19/2011 | US20110117029 Water-soluble anionic bacteriochlorophyll derivatives and their uses |
05/19/2011 | US20110117027 Injectable void filler for soft tissue augmentation |
05/19/2011 | US20110117026 Methods and compositions for the delivery of bioactive compounds |
05/19/2011 | US20110117024 Nanocarrier and nanogel compositions |
05/19/2011 | US20110117023 Contrast agent for photoacoustic imaging and photoacoustic imaging method using the same |
05/19/2011 | US20110117022 Method of using and establishing an absorption rate level and a neuron firing level |
05/19/2011 | US20110117021 Fully human anti-vap-1 monoclonal antibodies |
05/19/2011 | US20110117020 Imaging dendrimer nanoprobes and uses thereof |
05/19/2011 | US20110117019 Novel Compositions and Uses Thereof |
05/19/2011 | US20110117018 Compositions and methods for treating bone |
05/19/2011 | US20110117017 Peptides with properties of an allosteric antagonist selective for the alpha 1a adrenergic receptor and uses thereof |
05/19/2011 | US20110117015 Diagnostic Agents Selective Against Metalloproteases |
05/19/2011 | US20110117013 Compositions against cancer antigen liv-1 and uses thereof |
05/19/2011 | US20110117010 Methods and Compositions for Administering Therapeutic and Diagnostic Agents |
05/19/2011 | US20110117009 Drug conjugates with polyglycerols |
05/19/2011 | US20110117008 Use of avicins to deliver therapeutic and diagnostic agents |
05/19/2011 | CA2777682A1 Dendrimer compositions and methods of synthesis |
05/18/2011 | EP2322637A1 Transgenic non-human mammal comprising a polynucleotide encoding human or humanized C5AR |
05/18/2011 | EP2322548A1 NPC1L1 (NPC) and methods of use thereof |
05/18/2011 | EP2322538A1 Compounds for the diagnosis of diseases associated with VCAM expression |
05/18/2011 | EP2322213A1 Cancerous disease modifying antibodies |
05/18/2011 | EP2322143A1 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
05/18/2011 | EP2321613A1 Method and device for characterizing the effect of a skin treatment agent on skin |
05/18/2011 | EP2320955A1 Carbon nanotube based magnetic resonance imaging contrast agents |
05/18/2011 | EP2320954A1 Diagnostic agents selective against metalloproteases |
05/18/2011 | EP1701611B1 Transgenic non-human mammal comprising a polynucleotide encoding human or humanized c5ar |
05/18/2011 | CN102065906A Methods for radiolabelling macromolecules |
05/18/2011 | CN102065905A Methods for radiolabelling synthetic polymers |
05/18/2011 | CN102065904A Renal function analysis method and apparatus |
05/18/2011 | CN102061162A Method for preparing magneto-optic difunctional CNT/Fe304@SiO2 (FITC) (Fluorescein Isothiocyanate) one-dimensional nano composite material |
05/18/2011 | CN102058891A Fluorescent magnetic silicon nano carrier modified with polyethylene glycol and preparation method and application |
05/18/2011 | CN101031324B Diagnostic agent for tumor |
05/18/2011 | CN100998875B Acetic acid white detection sticking strip |
05/17/2011 | US7943775 to detect amyloid deposits prior to aggregation into plaques; labeled bifunctional compound binds to target protein and to chaperone protein; Alzheimer's; 1-[4-(carboxymethoxy)phenyl]-3-(3,4-dimethoxy-phenyl)-1-propanyl-1-(3,3-dimethyl-1,2-dioxopentyl)-2-piperidinecarboxylate isomers bind differently |
05/17/2011 | US7943738 IL-17 receptor like molecules and uses thereof |
05/17/2011 | US7943586 Antineoplastic agents targeted via glut transporters |
05/17/2011 | US7943343 Production and use of novel peptide-based agents for use with bi-specific antibodies |
05/17/2011 | US7943301 DNA conformational switches as sensitive electronic sensors of analytes |
05/17/2011 | US7943168 liquid hydrophobic core coated with a lipid/surfactant layer which contains the peptides; melittin |
05/17/2011 | US7943147 dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants |
05/17/2011 | CA2440045C Method for sample identification in a mammal as well as a kit for performing this method |
05/12/2011 | WO2011055121A1 Quantifying cell death |
05/12/2011 | WO2011054827A1 Process for the preparation of calcobutrol |
05/12/2011 | WO2011054112A1 Antibodies that specifically block the biological activity of kidney associated antigen 1 |
05/12/2011 | WO2011010848A9 Multifunctional nanoparticles for fluorescence, mr and pet images comprising magnetic silica nanoparticles doped with a near-infrared (nir) dye allowing composite imaging of lymph nodes and deep organs, and a method for synthesising the same |
05/12/2011 | WO2011008823A3 Peptide-mediated non-covalent delivery of active agents across the blood brain barrier |
05/12/2011 | WO2010128787A9 Gadolinium complex, method for preparing same, and mri contrast agent comprising same |
05/12/2011 | US20110113494 Serine Hydroxymethyltransferase as Target for Herbicides |
05/12/2011 | US20110110902 Means and methods for counteracting, delaying and/or preventing heart disease |
05/12/2011 | US20110110868 Functionalized Magnetic Nanoparticles and Methods of Use Thereof |
05/12/2011 | US20110110867 Multimodal imaging method using nano-emulsion comprising optical nano-particles and perfluorocarbons |
05/12/2011 | US20110110866 Elastin-like polypeptide and gadolinium conjugate for magnetic resonance imaging |
05/12/2011 | US20110110865 Chelatros, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
05/12/2011 | US20110110864 Fluorescent nanocrystals encapsulated in an inorganic shell |
05/12/2011 | US20110110863 Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications |
05/12/2011 | US20110110862 Disease animal model for chronic pain |
05/12/2011 | US20110110861 Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells |
05/12/2011 | US20110110860 Modulation of ldl receptor gene expression with double-stranded rnas targeting the ldl receptor gene promoter |
05/12/2011 | US20110110859 Protein |
05/12/2011 | US20110110858 Gold nanoparticle imaging agents and uses thereof |
05/12/2011 | US20110110857 Mutant forms of chlamydia htra |
05/12/2011 | US20110110856 Optimized Adhesin Fragments And Corresponding Nanoparticles |
05/12/2011 | US20110110855 Novel ghrelin analogues |
05/12/2011 | US20110110854 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules |
05/12/2011 | US20110110853 Primitive vascular progenitor cells and uses thereof |
05/12/2011 | US20110110852 Multivalent Antibodies and Uses Therefor |
05/12/2011 | US20110110850 Compounds for therapy and diagnosis |
05/12/2011 | CA2816437A1 Antibodies that specifically block the biological activity of kidney associated antigen 1 |
05/12/2011 | CA2777314A1 Process for the preparation of calcobutrol |
05/11/2011 | EP2319869A1 ANTIBODY AGAINST OXIDIZED LDL/ß²GPI COMPLEX AND USE OF THE SAME |
05/11/2011 | EP2319864A2 Nematoden als Modellorganismen zur Untersuchung neurodegenerativer Erkrankungen und insbesonder der parkinsonschen Erkrankung, Verwendung und Verfahren |
05/11/2011 | EP2319544A1 Cellular labeling for nuclear magnetic resonance techniques |
05/11/2011 | EP2319536A1 Inhibiting CAV3 isoforms and the delta25B splice varients for the diagnosis and treatment of cancer |
05/11/2011 | EP2319515A1 Coccidicide combination for veterinary use |
05/11/2011 | EP2319399A2 Fluorescence-mediated molecular tomography |
05/11/2011 | EP2318052A1 Nanocrystal nano-emulsion |
05/11/2011 | EP2318051A2 In vitro diagnostic markers comprising carbon nanoparticles and kits |
05/11/2011 | EP2317916A2 Improved techniques for magnetic particle imaging |
05/11/2011 | EP2317911A2 Transcutaneous organ function measurement |
05/11/2011 | EP1874370B1 Non-degradable low swelling, water soluble radiopaque hydrogels |
05/11/2011 | EP1191946B1 Dental moulding- or filmmaterials and imaging method for intraoral diagnostic purposes |
05/11/2011 | EP0885002B1 Materials and methods for enhancing cellular internalization |
05/11/2011 | CN1899614B Preparation for the prophylaxis of restenosis |
05/11/2011 | CN102049052A Method for preparing monodispersed and uniform single core-supported silicon oxide-wrapped hydrophobic nanocrystalline |
05/11/2011 | CN102049046A Application of delta opioid receptor antagonist to relief of Alzheimer's disease |
05/11/2011 | CN101564540B Preparation method of Gd-DTPA-Polylysine-McAb junctional complex |
05/11/2011 | CN101314048B Body mould for mri and MRI system |
05/10/2011 | US7939654 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
05/10/2011 | US7939625 Somatostatin analogues |
05/10/2011 | US7939170 Water soluble metal and semiconductor nanoparticle complexes |
05/10/2011 | US7939085 Attenuated myxomavirus that has lost receptor properties of myxomavirus interferon receptor or myxomavirus tumor necrosis factor receptor or myxomavirus interleukin receptor; causes an increase in number of leukocytes in human patient 7 days after administration |
05/10/2011 | US7939052 Method of measuring the biological activity of an urotensin II receptor |